LUXI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 964
EU - Europa 872
AS - Asia 708
SA - Sud America 101
AF - Africa 61
OC - Oceania 1
Totale 2.707
Nazione #
US - Stati Uniti d'America 894
RU - Federazione Russa 499
SG - Singapore 354
IT - Italia 148
CN - Cina 102
VN - Vietnam 75
BR - Brasile 74
HK - Hong Kong 74
CA - Canada 57
GB - Regno Unito 51
DE - Germania 37
FR - Francia 28
FI - Finlandia 27
IN - India 26
KR - Corea 23
IE - Irlanda 18
SE - Svezia 18
BJ - Benin 14
NG - Nigeria 12
TG - Togo 12
ZA - Sudafrica 12
AR - Argentina 10
BD - Bangladesh 10
AT - Austria 9
JP - Giappone 9
NL - Olanda 9
MX - Messico 8
PL - Polonia 8
TR - Turchia 7
ES - Italia 6
CL - Cile 4
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
UA - Ucraina 3
UZ - Uzbekistan 3
CO - Colombia 2
EG - Egitto 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
UY - Uruguay 2
AD - Andorra 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 2.707
Città #
Singapore 229
Dallas 221
Moscow 166
Ashburn 153
San Jose 127
Verona 76
Hong Kong 74
Chandler 40
Los Angeles 31
Ho Chi Minh City 28
Toronto 26
Beijing 22
New York 22
The Dalles 22
London 18
Helsinki 17
Dublin 16
Cotonou 14
São Paulo 14
Hamilton 13
Buffalo 12
Lomé 12
Abuja 11
Council Bluffs 11
Hanoi 11
Johannesburg 11
Montreal 11
Amsterdam 9
Catania 9
Tokyo 9
Chennai 8
Da Nang 8
Orem 8
Poplar 8
Santa Clara 8
Boardman 7
Rome 7
Boydton 6
Hyderabad 6
Redondo Beach 6
Seattle 6
Seoul 6
Chions 5
Columbus 5
Denver 5
Falkenstein 5
Misterbianco 5
Munich 5
Nuremberg 5
Southend 5
Stockholm 5
Warsaw 5
Ankara 4
Atlanta 4
Chicago 4
Lawrence 4
Madrid 4
Monserrato 4
Mumbai 4
North Bergen 4
Phoenix 4
Princeton 4
Redmond 4
Bonavigo 3
Brooklyn 3
Frankfurt am Main 3
Guangzhou 3
Jakarta 3
Lappeenranta 3
Mexico City 3
Milford 3
Palermo 3
Piscataway 3
Roubaix 3
Sindelfingen 3
Tashkent 3
Turku 3
Vienna 3
Washington 3
Wroclaw 3
Baghdad 2
Belo Horizonte 2
Bengaluru 2
Campo Grande 2
Cernusco sul Naviglio 2
Concord 2
Darmstadt 2
Dhaka 2
Fernandina Beach 2
Graz 2
Greenville 2
Haiphong 2
Houston 2
Hải Dương 2
Kuala Lumpur 2
Kyiv 2
La Paz 2
Manchester 2
Mezzocorona 2
Milan 2
Totale 1.704
Nome #
Safety Profile of Antiviral Therapies for the Early Treatment/Prevention of COVID-19: Analysis of the International Pharmacovigilance Database VigiBase 225
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 203
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 194
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBase 138
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 137
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System 133
Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies 133
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 132
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study 131
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy 129
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study 126
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study 126
Anaphylaxis due to antiallergic and antiasthmatic biologics 119
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database 112
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports 110
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study 105
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study 104
Terapia immunosoppressiva di mantenimento nei pazienti sottoposti a trapianto di organo solido: survey delle esperienze dai centri-trapianto italiani 103
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase® 98
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose 82
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group” 79
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women 33
Monitoraggio della sicurezza dei vaccini COVID-19 in popolazioni speciali attraverso sistemi di farmacovigilanza attiva: risultati del progetto europeo Covid-Vaccine-Monitor 12
Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study 2
Totale 2.766
Categoria #
all - tutte 9.100
article - articoli 8.708
book - libri 0
conference - conferenze 310
curatela - curatele 0
other - altro 82
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 7 0 2 13 2 2 1 1 0 2 14
2022/2023142 14 14 6 23 2 24 0 12 15 5 20 7
2023/2024171 4 21 13 12 13 22 10 11 7 24 17 17
2024/2025506 30 14 47 85 21 33 15 16 81 41 51 72
2025/20261.903 92 169 172 309 485 116 196 105 87 116 30 26
Totale 2.766